Evaluating only TeVido BioDevices’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Regulation.
Key Events Timeline
FOUNDING
Laura Bosworth and Thomas Boland found TeVido BioDevices in Austin, targeting bioprinted fat tissue for breast reconstruction.
FUNDING
TeVido appears on Shark Tank Season 6; NSF SBIR grants secured totaling ~$750K for pre-clinical research phase.
REGULATORY ACTION
FDA IND filing preparations reveal $15M+ clinical trial cost estimates; TeVido unable to raise Series A to fund path to approval.
SHUTDOWN
TeVido BioDevices dissolved after exhausting funding; founders move on to other ventures without achieving commercial bioprinting milestone.
Full Analysis
Free · no account needed
Documented cause
TeVido BioDevices, founded by Laura Bosworth and Thomas Boland in Austin, Texas, raised around $4M to develop bioprinted adipose tissue for breast reconstruction and nipple tattoo correction post-mastectomy. Despite appearing on Shark Tank Season 6 and winning National Science Foundation grants, the company failed to reach IND (Investigational New Drug) application stage with the FDA. Clinical development costs overwhelmed the team and the company was dissolved in 2018 without a commercial product.
Lesson
“Biotech startups solving real medical needs still fail without a funded clinical development plan matching FDA requirements.”